Skip to main content
Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
2.100
+0.230 (12.30%)
At close: Jun 26, 2026, 4:00 PM EDT
2.100
0.00 (0.00%)
After-hours: Jun 26, 2026, 7:55 PM EDT

Fate Therapeutics Employees

Fate Therapeutics had 161 employees as of December 31, 2025. The number of employees decreased by 20 or -11.05% compared to the previous year.

Employees
161
Change (1Y)
-20
Growth (1Y)
-11.05%
Revenue / Employee
$39,230
Profits / Employee
-$806,876
Market Cap
244.77M

Employees Chart

Employees History

Date Employees Change Growth
Dec 31, 2025161-20-11.05%
Dec 31, 20241810-
Dec 31, 2023181-370-67.15%
Dec 31, 202255110222.72%
Dec 31, 202144917060.93%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Related Stocks

Company Name Employees
Karyopharm Therapeutics 228
Coherus Oncology 145
Nautilus Biotechnology 127
AC Immune 122
Invivyd 122
Foghorn Therapeutics 106
Orchestra BioMed Holdings 86
Fulcrum Therapeutics 55
Employee Rankings

FATE News

More News